SAN

82.76

-0.81%↓

MRK1

109.8

+0.23%↑

SHL.DE

46.12

+0.28%↑

ARGX

481

-1.13%↓

FRE

41.43

-1.12%↓

SAN

82.76

-0.81%↓

MRK1

109.8

+0.23%↑

SHL.DE

46.12

+0.28%↑

ARGX

481

-1.13%↓

FRE

41.43

-1.12%↓

SAN

82.76

-0.81%↓

MRK1

109.8

+0.23%↑

SHL.DE

46.12

+0.28%↑

ARGX

481

-1.13%↓

FRE

41.43

-1.12%↓

SAN

82.76

-0.81%↓

MRK1

109.8

+0.23%↑

SHL.DE

46.12

+0.28%↑

ARGX

481

-1.13%↓

FRE

41.43

-1.12%↓

SAN

82.76

-0.81%↓

MRK1

109.8

+0.23%↑

SHL.DE

46.12

+0.28%↑

ARGX

481

-1.13%↓

FRE

41.43

-1.12%↓

Search

Vetoquinol SA

Fermé

SecteurSoins de santé

79.9 2.17

Résumé

Variation du prix de l'action

24h

Actuel

Min

77.5

Max

79.9

Chiffres clés

By Trading Economics

Revenu

35M

Ventes

275M

P/E

Moyenne du Secteur

15.06

39.564

Rendement du dividende

1.2

Marge bénéficiaire

12.694

Employés

2,437

EBITDA

60M

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.20%

2.40%

Prochains Résultats

11 sept. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

904M

Ouverture précédente

77.73

Clôture précédente

79.9

Sentiment de l'Actualité

By Acuity

34%

66%

82 / 376 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bearish Evidence

Vetoquinol SA Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 juil. 2025, 22:07 UTC

Principaux Mouvements du Marché

Trade Desk Rises on S&P 500 Inclusion

14 juil. 2025, 17:06 UTC

Principaux Mouvements du Marché

Crypto Assets Rally Ahead of Possible U.S. Legislation

14 juil. 2025, 16:47 UTC

Acquisitions, Fusions, Rachats

NatWest to Sell Stake in Permanent TSB

14 juil. 2025, 23:46 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

14 juil. 2025, 23:38 UTC

Market Talk

Gold Edges Higher Ahead of U.S. CPI Data -- Market Talk

14 juil. 2025, 23:37 UTC

Market Talk

ANZ's Institutional Earnings Likely to Weigh on Outlook -- Market Talk

14 juil. 2025, 23:29 UTC

Market Talk

South32 Bull Eyes Possible Last-Minute Power Deal for Mozal -- Market Talk

14 juil. 2025, 23:29 UTC

Market Talk

Global Energy Roundup: Market Talk

14 juil. 2025, 23:02 UTC

Résultats

China Vanke: Additional Provision for Asset Impairment Also Among Factors Weighing on Results >000002.SZ

14 juil. 2025, 23:02 UTC

Résultats

China Vanke: Weakness in Overall China Real-Estate Sector Weighed on Results >000002.SZ

14 juil. 2025, 23:02 UTC

Résultats

China Vanke 1H Loss Was CNY9.85B >000002.SZ

14 juil. 2025, 23:01 UTC

Résultats

China Vanke Sees 1H Loss CNY10.0B-Loss CNY12.0B >000002.SZ

14 juil. 2025, 23:01 UTC

Résultats

China Vanke Expects 1H Loss to Widen >000002.SZ

14 juil. 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

14 juil. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 juil. 2025, 20:07 UTC

Market Talk

Cloud Computing Giants Will Be the Winner from Software's Loss -- Market Talk

14 juil. 2025, 20:05 UTC

Market Talk

Adobe and Salesforce May Struggle to Keep Up With AI Agents -- Market Talk

14 juil. 2025, 19:11 UTC

Market Talk

Oil Retreats Despite Trump Threats of Russia Sanctions -- Market Talk

14 juil. 2025, 19:09 UTC

Market Talk

Gold Breaks a 3-Day Win Streak -- Market Talk

14 juil. 2025, 18:59 UTC

Market Talk

Hotter Weather Outlook, LNG Flows Boost U.S. Natural Gas -- Market Talk

14 juil. 2025, 18:30 UTC

Acquisitions, Fusions, Rachats

Synopsys Buy of Ansys Gets China OK. The $35 Billion Deal Is Set to Close. -- Barrons.com

14 juil. 2025, 18:25 UTC

Market Talk

Dollar Gains, Treasury Yields Lose Steam as Trump Threatens Russia -- Market Talk

14 juil. 2025, 18:25 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14 juil. 2025, 16:59 UTC

Market Talk

Goldman Sachs Lifts 2H25 Crude Price Views -- Market Talk

14 juil. 2025, 16:53 UTC

Actions en Tendance

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14 juil. 2025, 16:27 UTC

Market Talk

Oil Falls as Investors Monitor U.S.-EU Trade, Trump's Russia Sanction Threats -- Market Talk

14 juil. 2025, 16:20 UTC

Market Talk
Résultats

Auto & Transport Roundup: Market Talk

14 juil. 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 juil. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

14 juil. 2025, 16:12 UTC

Market Talk
Acquisitions, Fusions, Rachats

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

Comparaison

Variation de prix

Vetoquinol SA prévision

Note du Consensus

By TipRanks

0 ratings

0

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

72.6 / 75.1Support & Résistance

Court Terme

Bearish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

82 / 376Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.